Actual costs of cancer drugs in 15 European countries

Wim H. van Harten, Anke Wind, Paolo de Paoli, Mahasti Saghatchian, Simon Oberst

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)18-20
Number of pages3
JournalThe Lancet Oncology
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

ASJC Scopus subject areas

  • Oncology

Cite this

van Harten, W. H., Wind, A., de Paoli, P., Saghatchian, M., & Oberst, S. (2016). Actual costs of cancer drugs in 15 European countries. The Lancet Oncology, 17(1), 18-20. https://doi.org/10.1016/S1470-2045(15)00486-6